USPTO serial 79130159
VARITHENA
Reviewed by CopyMark Law Group
Reg. 4516822Status 739Registered
- Filing date
- Status date
- Registration date
- Apr 22, 2014
- Examiner
- RITTNER, HANNO I
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with VARITHENA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lori A. Ruhly
Lori A. Ruhly Quarles & Brady LLP33 East Main Street, Suite 900Madison, WI 53703United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the production of injectable foams ] | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations in the form of foams for use in the treatment of sclerotherapy of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in the treatment of sclerotherapy of veins; pharmaceutical preparations, including preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology [ and proctology, for treatment of oesophageal varices, hydroceles, ] in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations | ACTIVE | — |
| 010 | Cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations [, oesophageal varices and hydroceles ]; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations [, oesophageal varices and hydroceles ]; surgical and medical apparatus for producing and administering sclerosing foams; surgical and medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology [, or proctology ]; surgical or medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations [, oesophageal varices or hydroceles ]; devices for assessing the physical characteristics of such foams, devices for intravenous administration of foam and devices for monitoring the position and effect of foam in the human body; diagnostic devices for use in all the above medical conditions | ACTIVE | — |
| 042 | [ Scientific research services related to sclerotherapy of veins including provision of treatment in the fields of phlebology, proctology and angiology ] | SECTION 71 - CANCELLED | — |
| 044 | [ Medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical health assessment services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterlisation treatment; medical treatment services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical after-care services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Provensis Limited
- Other trademarks owned by Provensis Limited
- Other trademarks owned by BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED
- Other trademarks owned by Provensis Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named VARITHENA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 13, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 3, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 3, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 3, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 19, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 16, 2024 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Apr 16, 2024 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 11, 2024 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Sep 23, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 22, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 22, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 22, 2023 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| May 22, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 22, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 22, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Oct 20, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 8, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 20, 2021 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 19, 2021 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 19, 2021 | INPC | INVALIDATION PROCESSED | — |
| Jan 15, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 15, 2020 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| May 15, 2020 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| May 1, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 25, 2020 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Apr 22, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 13, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 10, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 3, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 3, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 22, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 22, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 4, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 4, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 2, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 15, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 15, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 15, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 2, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 31, 2013 | ALIE | ASSIGNED TO LIE | — |
| Dec 18, 2013 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2013 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 5, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 3, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 3, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 24, 2013 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 7, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 5, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 5, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 5, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 4, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 3, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 31, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 30, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |